__NUXT_JSONP__("/drugs/Iodine_I_131_Tositumomab", (function(a,b,c,d){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"192391-48-3",chebiId:b,chemicalFormula:b,definition:"A monoclonal antibody directed against the CD20 protein expressed on the surface of B-lymphocytes and radiolabeled with the radioisotope iodine I 131 with potential antineoplastic activity. Iodine I 131 tositumomab binds to and selectively delivers cyctotoxic radiation to CD20-expressing B-lymphocytes, thereby minimizing systemic radiotoxicity.",fdaUniiCode:"K1KT5M40JC",identifier:"C2444",preferredName:c,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129819","C1511"],synonyms:["131-I-Anti-B1 Monoclonal Antibody","Bexxar","I 131 Monoclonal Antibody Anti-B1","I 131 Tositumomab","I131-MOAB-B1","Iodine I 131 MOAB Anti-B1","Iodine I 131 Monoclonal Antibody Anti-B1",c,"Iodine-131 Anti-B1 Antibody","Iodine-131 Anti-CD20 Monoclonal Antibody","Iodine-131 Tositumomab","TOSITUMOMAB I-131","iodine I 131 tositumomab"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FIodine_I_131_Tositumomab",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("Iodine_I_131_Tositumomab","","Iodine I 131 Tositumomab","2021-10-30T13:37:41.043Z")));